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CUSHING'S SYNDROME CAUSED 
BY ECTOPIC ACTH SECRETION 
FROM PULMONARY TUMOURLETS 
F J Pirie, A A Motala, A Amod, R Chetty, S R Thomson, 
S Lalloo, M A K Omar 
Ectopic adrenocorticotrophic hormone (ACTH) secretion 
accounts for 9 - 18% of all causes of Cushing's syndrome.' The 
commonest source of the ectopic ACTH syndrome is carcinoma 
of the lung, with a smaller contribution from carcinoid 
tumours. While bronchial carcinoid tumours are reported to be 
responsible for 5-39% of ectopic ACTH-associated Cushing's 
syndrome, pulmonary tumourlets, which represent an 
uncommon form of neuroendocrine proliferation, may rarely 
give rise to Cushing's syndrome by secreting ACTHY This 
report details the identification of two such cases presenting to 
the Endocrine Unit at King Edward VIll Hospital, Durban, 
South Africa. 
CASE1 
A 38-year-old woman was referred to King Edward VIll 
Hospital from a rural area in August 1993 for management of 
Cushing's syndrome. She gave a history of weight gain and 
mood changes of 3 months' duration. There was no menstrual 
irregularity and no respiratory symptoms were reported. The 
referring hospital noted that she had a Cushingoid habitus and 
was hypertensive. Physical examination confirmed features 
typical of Cushing's syndrome associated with severe 
hypertension, with no evidence of end-organ damage. There 
was inadequate serum cortisol suppression with the standard 
low-dose dexamethasone suppression test (serum cortisol 
390 nmol/l after dexamethasone 0.5 mg 6-hourly for 48 hours), 
and midnight serum cortisol was 802 nmol/1 with 
corresponding plasma ACTH 60 pg/ ml, indicating ACTH-
mediated hypercortisolaemia v.rith no circadian variation. 
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Serum cortisol fell to 183 nmol/1 after the high-dose 48-hour 
dexamethasone suppression test. A magnetic resonance image 
(MRI) scan of the pituitary revealed a right-sided 
microadenoma. On the basis of the suppression achieved with 
the high-dose dexamethasone suppression test and the 
demonstration of a pituitary lesion, a trans-sphenoidal 
procedure was undertaken in December 1993. The surgeon 
failed to locate the adenoma and the tissue submitted for 
histological examination revealed normal pituitary tissue. A 
second attempt to resect the lesion was undertaken in 
September 1994 through a right fronto-temporal craniotomy. 
Postoperatively generalised seizures occurred, requiring 
chronic therapy with phenytoin, and pituitary insufficiency 
ensued, requiring therapy with desmopressin, levothyroxine 
and cyclical oestrogen and progesterone. The clinical features lf 
Cushing's syndrome persisted. 
In June 1995 a chest radiograph showed bilateral fine 
nodular opacities of mid- and lower zonal distribution 
suggestive of miliary tuberculosis. Tuberculosis chemotherap: 
was commenced. In January 1996, midnight serum cortisol an l 
plasma ACTH measured 798 nmol / l and 70.2 pg/ ml 
respectively. Repeat chest radiograph remained unchanged, 
despite tuberculostatic therapy. High resolution computed 
tomography scan (Philips Tomoscan LX) demonstrated 
multiple non-calcified uodules 2- 10 mm in size ·in a random 
distribution within the mid- and lower zones of both lungs 
(Fig. 1). While most nodules were discrete, the largest 
demonstrated marginal spiculation and pleural tags (Fig. 1). 
These findings were considered to represent peribronchiolar 
fibrosis. The differential diagnosis for these HRCT findings 
included granulomatous disorders (including tuberculosis an 
sarcoidosis), metastatic tumour deposits and lymphoma. The: ! 
were no respiratory symptoms. A transbronchiallung biopsy 
Fig. 1. HRCT scan demonstrating pulmonan; nodule (a rrow) with 
spiculation and pleural tag. 
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·vealed nonspecific chronic inflammation and octreotide 
. :intigraphy failed to d emonstrate any areas of abnormal 
ptake. A repeat high-dose d examethasone suppression test 
emonstrated lack of suppression (baseline serum cortisol 
' l8 nmol/1, post-test serum cortisol 658 nmol/1). An open lung 
l 10psy was performed in June 1998. The resected specimen 
emonstrated multiple carcinoid tumourlets with positive 
CTH immunostaining. The lesions were too widespread for 
·section and bilateral adrenalectomy was offered . The patient 
, ~dined any further surgical intervention and was given 
I ctoconazole. Following admission to hospital with acute 
1olecystitis in September 1999, the patient died suddenly of 
1 unknown cause. The family refused permission to perform a 
1strnortem examination. 
:ASE2 
17-year-old male patient was referred in August 1997 with a 
agnosis of cyclical Cushing's syndrome. He had originally 
1 esented to a paediatrician at the age of 11 years with 
~urrent nephrolithiasis and weight gain. A diagnosis of 
' hing's syndrome was made (the details of which were not 
ailable to this unit), but spontaneous clinical and biochemical 
·nission occurred before completion of the diagnostic 
' a!uation . During the following 5 years four clinical relapses 
d spontaneous remissions occurred, each episode self-treated 
1 iefly with bromocriptine. In 1997, the clinical signs failed to 
sress with bromocriptine therapy, effort-induced dyspnoea 
' veloped and frequent episodes of nep hrolithiasis occurred, 
r =juiring extra-corporeal shock wave lithotripsy on two 
{ casions. ACTH-dependent Cushing's syndrome was 
monstrated, with plasma ACTH 75 pg/ rnl. There was failure 
' serum cortisol suppression with the 8 mg overnight 
r ·xamethasone suppression test. Computed tomography (CT) 
s m of the pituitary revealed a left-sided rnicroadenoma. 
lt ferior petrosal venous sinus sampling failed to demonstrate a 
c,ntral/peripheral ACTH gradient and octreotide scintigraphy 
f o~ led to show any abnormal areas. In August 1997, 24-hour 
u~ine 5-hydroxyindole-acetic acid excretion measured 52 !Jmol 
(ttormal < 50 !lffiOl per 24 hour). The patient defaulted further 
fullow-up until late 1998. On re-evaluation, a chest radiograph 
showed bilateral pulmonary nodules of varying size, with 
predominant involvement of the left ba e. This wa interpreted 
as bronchiectasis with mucous plugs. An HRCT scan of the 
chest revealed bilateral non-calcified nodules 2 - 20 mm in size 
in a distinct peribronchiolar distribution, with clustering in 
parts (Fig. 2). An open lung biopsy was performed in January 
1999 and histological examination revealed multiple_ ~odules of 
carcinoid tumour cells in cords and sheets, with posibVe ACTH 
inlrnunostaining. As with the first patient, the le ions were too 
Widespread for resection . In March 1999, bilateral . 
adrenalectomy and ureterolithotomy were performed VIa an 
anterior approach as a combined single stage procedure. Both 
Fig. 2. HRCT scan demonstrating peribronchiolar distribution of 
nodules with clustering (arrows). 
adrenal glands revealed histological evidence of adrenocortical 
hyperplasia. The postoperative period was complicated by 
partial septic wound dehiscence from a right peri-ureteric 
abscess that developed as a result of persistent urine leak from 
the ureterolithotomy. This required formal retroperitoneal 
drainage and prolonged ureteric stenting. At pre ent the 
patient is asymptomatic, on glucocorticoid and 
mineralocorticoid replacement therapy. 
D ISCUSSION 
Both patients manifested a highly unusual form of ectopic 
ACTH-associated Cu hing' syndrome. ln both case 
periodicity of ecretion was noted biochemically, and to a lesser 
extent clinically. Furthermore, in both patients pituitary 
imaging was misleading (incidentally identifyin g non-
functional pituitary adenomas); in the first case, the a sociated 
finding of uppression of serum corti ol after admirli. tration of 
high-dose dexamethasone resulted in inappropriate 
hypophysectomy. Incidental detection of pituitary adenomata 
have been reported in 27% of postmortem exa.rninations3 and 
10% of subjects in the 30 - 40-year age group on MRI.' The 
clinical sigrUficance of a pituitary adenoma, detected with MRl 
scanning, must therefore be interpreted in conjunction with the 
biochemical data to avoid fal e-positives, a in the cases 
reported here. There is no way of d i criminating between an 
incidental adenoma and an actively secreting pituitary lesion 
using current imaging techniques. Periodic relea e of ACTH by 
benign extra-pituitary tumour has been previously reported.' 
These tumour may retain partial ensiti ity to feedback 
inhibition by high do es of exogenous glucocorticosteroids and 
thus mimic pituitary ACTH-secreting adenomas.' Both cases 
demonstrated periods during which suppression of serum 
cortisol wa achieved with high-do e dexamethasone, as well 
as periods of failed suppre ion. Thi was possibly owing to 
partial ACTH sensitivity or periodicity of ACTH secretion. This 
ob ervation highlights the need for definitive demonstration of 
the ACTH ource before surgical intervention. 
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Corticotrophin-releasing hormone (CRH) stimulation tests 
were not done in either case because of the non-availability of 
this pituitary secretagogue at this institute. The CRH test is 
used as a means of differentiating eutopic from ectopic ACTH 
secretion, based on the principle that corticotroph adenomas 
express CRH receptors in greater numbers than ectopic ACTH 
sources.• It is probable that the test would have assisted in 
identifying an ectopic ACTH source, although this is 
speculative. The National Institutes of Health (NIH) study on 
the clinical utility of the CRH test reported a sensitivity of 93% 
and specificity of 100% in discriminating pituitary from ectopic 
ACTH sources (including 13 cases of carcinoid tumours). The 
criterion used was a mean plasma ACTH increment of 35% 
above the basal value at 15 and 30 minutes after the injection as 
being indicative of a pituitary ACTH source. Mean serum 
cortisol increments of 20% or more above the basal level at 30 
and 45 minutes resulted in a sensitivity of 91% and specificity 
of 88% in the same NIH study.' There were no cases of 
pulmonary tumourlets in this study and in the case of 
pulmonary tumourlets reported by Arioglu and colleagues2 
from the same centre, CRH testing was not performed. 
In both cases abnormal chest radiographs were present for a 
number of years before the diagnoses were established. The 
radiographs were misinterpreted as miliary tuberculosis in the 
first patient and bronchiectasis with mucous plugs in the 
second patient. Both of these conditions are seen with great 
frequency in this environment. either patient had significant 
respiratory symptoms with effort, nor were any auscultatory 
abnormalities evident, therefore indicating slow growth of the 
pulmonary lesions. Pulmonary tumourlets are generally 
located in the bronchiolar mucosa and submucosa• and this 
anatomical siting is probably responsible for the silent nature 
of the lesions in most cases. The release of neuropeptides is 
thought to mediate the development of peribronchiolar 
fibrosis, as was seen on the HRCT scan in case 1.9 The natural 
history of pulmonary tumour lets is not well documented in 
view of the relatively few cases that have been d~scribed. 
Malignant transformation has, however, been documented in at 
least one previous report. 10 
Much of the literature pertaining to bronchopulmonary 
carcinoid secretion of ectopic ACTH is related to discrete 
neoplasms, rather than the diffuse tumour lets observed in 
these two cases. ' Pulmonary tumourlets have an obscure origin 
and have been considered to reflect uncontrolled hyperplasia 
of neuroendocrine tissue that is normally found in the 
bronchiolar mucosa of the adult lung.~u Stimuli for the 
exuberant growth of this tissue to the extent witnessed in these 
two cases are not known. In other situations a history of 
cigarette smoking has been associated with pulmonary 
neuroendocrine cell hyperplasia, although to a lesser degree 
than in the two cases reported here." The two patients differed 
in terms of age, ethnidty and geographical location and it 
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would therefore be difficult to implicate a common 
environmental precipitant. It is possible that pulmonary 
tumourlets and carcinoid tumours represent a continuum of 
pulmonary neuroendocrine cell growth, although genotypic 
differences between the cells of each of these conditions have 
been described, implying that the two conditions may be 
separate disorders.• 
In conclusion, two cases of Cushing's syndrome caused by 
ectopic ACTH secretion from pulmonary tumourlets are 
described, with both cases demonstrating periodicity of 
hormone secretion and dexamethasone responsiveness, with 
minimal clinical evidence of pulmonary disease. Both cases 
illustrate the necessity of following a structured algorithm of 
clinical and laboratory evaluation in patients with Cushing's 
syndrome before embarking on surgical intervention. 
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